These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32192076)

  • 1. Cryptides Identified in Human Apolipoprotein B as New Weapons to Fight Antibiotic Resistance in Cystic Fibrosis Disease.
    Gaglione R; Cesaro A; Dell'Olmo E; Di Girolamo R; Tartaglione L; Pizzo E; Arciello A
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
    Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
    BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
    Lashua LP; Melvin JA; Deslouches B; Pilewski JM; Montelaro RC; Bomberger JM
    J Antimicrob Chemother; 2016 Aug; 71(8):2200-7. PubMed ID: 27231279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-pseudomonal activity of new ß-Ala modified analogues of the antimicrobial peptide anoplin.
    Zhong C; Zhu Y; Zhu N; Liu T; Gou S; Zhang F; Yao J; Xie J; Ni J
    Int J Med Microbiol; 2020 Jul; 310(5):151433. PubMed ID: 32654770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y; Huang J; Li L; Liu L
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 11. The problems of antibiotic resistance in cystic fibrosis and solutions.
    López-Causapé C; Rojo-Molinero E; Macià MD; Oliver A
    Expert Rev Respir Med; 2015 Feb; 9(1):73-88. PubMed ID: 25541089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic and antibiofilm properties of ocellatin peptides against multidrug-resistant Pseudomonas aeruginosa.
    Bessa LJ; Eaton P; Dematei A; Plácido A; Vale N; Gomes P; Delerue-Matos C; Sa Leite JR; Gameiro P
    Future Microbiol; 2018 Feb; 13():151-163. PubMed ID: 29308671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversification of Pseudomonas aeruginosa within the cystic fibrosis lung and its effects on antibiotic resistance.
    Clark ST; Guttman DS; Hwang DM
    FEMS Microbiol Lett; 2018 Mar; 365(6):. PubMed ID: 29401362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking RpoN reduces virulence of Pseudomonas aeruginosa isolated from cystic fibrosis patients and increases antibiotic sensitivity in a laboratory strain.
    Lloyd MG; Vossler JL; Nomura CT; Moffat JF
    Sci Rep; 2019 Apr; 9(1):6677. PubMed ID: 31040330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. l-Methionine anti-biofilm activity against Pseudomonas aeruginosa is enhanced by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor.
    Cho DY; Lim DJ; Mackey C; Weeks CG; Peña Garcia JA; Skinner D; Grayson JW; Hill HS; Alexander DK; Zhang S; Woodworth BA
    Int Forum Allergy Rhinol; 2018 May; 8(5):577-583. PubMed ID: 29412515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action.
    Cappiello F; Di Grazia A; Segev-Zarko LA; Scali S; Ferrera L; Galietta L; Pini A; Shai Y; Di YP; Mangoni ML
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7252-7262. PubMed ID: 27671059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.